[The application of hematopoietic growth factors in oncology].
Hoekman
K
K
Afd. Geneeskundige Oncologie, Academisch Ziekenhuis Vrije Universiteit, Amsterdam.
Wagstaff
J
J
Ossenkoppele
G J
GJ
Pinedo
H M
HM
D000970:Antineoplastic Agents / Q000009:adverse effects; D001853:Bone Marrow / Q000187:drug effects; D016026:Bone Marrow Transplantation; D006410:Hematopoiesis / Q000187:drug effects*; D016298:Hematopoietic Cell Growth Factors / Q000096:biosynthesis / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D009196:Myeloproliferative Disorders / Q000188:drug therapy; D009369:Neoplasms / Q000188:drug therapy* / Q000378:metabolism; D010198:Pancytopenia / Q000139:chemically induced / Q000188:drug therapy
D000970:Antineoplastic Agents; D016298:Hematopoietic Cell Growth Factors